Stepan (NYSE:SCL – Get Free Report) was downgraded by research analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued on Saturday.
Stepan Price Performance
Shares of SCL stock opened at $49.82 on Friday. Stepan has a 12 month low of $44.23 and a 12 month high of $82.08. The company has a market capitalization of $1.12 billion, a P/E ratio of 19.61 and a beta of 0.98. The company has a current ratio of 1.35, a quick ratio of 0.79 and a debt-to-equity ratio of 0.31. The stock has a 50 day moving average of $55.80 and a two-hundred day moving average of $56.39.
Stepan (NYSE:SCL – Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The basic materials company reported $0.52 EPS for the quarter, missing analysts’ consensus estimates of $0.92 by ($0.40). Stepan had a net margin of 2.57% and a return on equity of 4.78%. The firm had revenue of $594.69 million during the quarter, compared to analyst estimates of $598.25 million. During the same quarter last year, the firm earned $0.41 earnings per share. Stepan’s quarterly revenue was up 6.9% on a year-over-year basis. As a group, equities analysts expect that Stepan will post 3.55 EPS for the current year.
Institutional Investors Weigh In On Stepan
Stepan Company Profile
Stepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products worldwide. It operates through three segments: Surfactants, Polymers, and Specialty Products. The Surfactants segment offers surfactants that are used in consumer and industrial cleaning and disinfection products, including detergents for washing clothes, dishes, carpets, and floors and walls, as well as shampoos and body washes; and other applications, such as fabric softeners, germicidal quaternary compounds, disinfectants, and lubricating ingredients.
Read More
- Five stocks we like better than Stepan
- How to Most Effectively Use the MarketBeat Earnings Screener
- Will Hims & Hers Fall Along With Novo Nordisk?
- Profitably Trade Stocks at 52-Week Highs
- Play It Cool: Why Comfort Systems USA Is a Hidden AI Winner
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Rocket Lab Reports Next Week: Here’s What Investors Should Know
Receive News & Ratings for Stepan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stepan and related companies with MarketBeat.com's FREE daily email newsletter.